Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

164
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
164
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

104
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
104
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

112
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
112
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

77
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
77
Mucosal Barrier of the Stomach01:25

Mucosal Barrier of the Stomach

683
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
683
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

438
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
438

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trial.

The lancet. Gastroenterology & hepatology·2026
Same author

Shifting the scope: Moving toward less invasive diagnosis and monitoring of eosinophilic esophagitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Baseline characteristics, treatment patterns, and long-term outcomes in patients with eosinophilic esophagitis initiating dupilumab in routine clinical practice: study protocol of a phase IV, prospective, observational, multicenter registry (EDESIA).

Therapeutic advances in gastroenterology·2026
Same author

The Epidemiology of Young-Onset Barrett's Esophagus in the United States: A National Population-Based Study Using the TriNetX Database.

Journal of clinical gastroenterology·2026
Same author

Prevalence and Predictors of Eosinophilic Esophagitis (EoE) Among Children With Severe Asthma.

The journal of allergy and clinical immunology. In practice·2026
Same author

Effect of Budesonide Oral Suspension on Time to First Dysphagia Symptom Response and Dysphagia Symptom Resolution Outcomes in Patients With Eosinophilic Esophagitis.

Journal of gastroenterology and hepatology·2026

相关实验视频

Updated: Jul 11, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

791

在异性食道炎中障碍障碍功能障碍.

Emily C McGowan1, Roopesh Singh2, David A Katzka3

  • 1Division of Allergy and Immunology, University of Virginia School of Medicine, PO Box 801355, Charlottesville, VA, 22908, USA. ekc5v@virginia.edu.

Current gastroenterology reports
|November 11, 2023
PubMed
概括
此摘要是机器生成的。

表皮屏障功能障碍是埃索诺菲尔性食道炎 (EoE) 的关键. 遗传和环境等因素加剧了这种情况,促进了炎症,并提出了新的治疗点.

关键词:
埃索诺菲尔性食道炎 (Eosinophilic Esophagitis) 是一种导致食道炎的疾病.皮质细胞上皮质细胞消化道障碍物 消化道障碍物这是TSLP的TSLP.

更多相关视频

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K
Surgical Models of Gastroesophageal Reflux with Mice
05:19

Surgical Models of Gastroesophageal Reflux with Mice

Published on: August 25, 2015

10.2K

相关实验视频

Last Updated: Jul 11, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
03:23

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis

Published on: May 10, 2024

791
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K
Surgical Models of Gastroesophageal Reflux with Mice
05:19

Surgical Models of Gastroesophageal Reflux with Mice

Published on: August 25, 2015

10.2K

科学领域:

  • 胃肠病学 胃肠病学
  • 免疫学 免疫学 免疫学
  • 细胞生物学 细胞生物学

背景情况:

  • 表皮屏障功能障碍越来越被认为是埃索诺菲尔性食道炎 (EoE) 病理生理学的核心.
  • 了解这种功能障碍的驱动因素对于开发有效治疗方法至关重要.

研究的目的:

  • 审查导致EOE上皮质屏障功能障碍的遗传,环境和免疫因素.
  • 探索皮质屏障受损如何加剧EoE的炎症.

主要方法:

  • 对研究EoE上皮质屏障功能的文献综述.
  • 对遗传,环境和免疫学因素的分析.
  • 检查分子机制,包括细胞因子效应和微生物变化.

主要成果:

  • 环境暴露 (例如洗剂) 直接影响食道屏障.
  • 由IL-13诱导的屏障功能障碍可以通过17β-雌激醇,维生素D和短链脂肪酸 (丁酸盐,酸盐) 减轻.
  • 多种因素汇聚在一起,损害了上皮屏障,促进了"Th2"免疫反应,失生症和抗原透.

结论:

  • 表皮屏障功能障碍是EoE的关键,多因素组成部分.
  • 针对障碍修复和缓解炎症途径的治疗策略显示出有前途.
  • 对这些因素的进一步研究可能会导致EoE的新型治疗方法.